Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Sell
46
GL Quote, Financials, Valuation and Earnings
Last price:
$129.77
Seasonality move
:
3.08%
Day range:
$127.39 - $130.17
52-week range:
$38.95 - $131.39
Dividend yield:
0.74%
P/E ratio:
10.86x
P/S ratio:
2.10x
P/B ratio:
2.05x
Volume:
789.9K
Avg. volume:
696K
1-year change:
12.4%
Market cap:
$10.9B
Revenue:
$5.8B
EPS (TTM):
$11.95
Analysts' Opinion
-
Consensus RatingGlobe Life has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $141.09, Globe Life has an estimated upside of 8.71% from its current price of $129.79.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $115.00 representing 100% downside risk from its current price of $129.79.
Fair Value
-
According to the consensus of 8 analysts, Globe Life has 8.71% upside to fair value with a price target of $141.09 per share.
GL vs. S&P 500
-
Over the past 5 trading days, Globe Life has overperformed the S&P 500 by 0.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Globe Life does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Globe Life has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Globe Life reported revenues of $1.5B.
Earnings Growth
-
Globe Life has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Globe Life reported earnings per share of $3.01.
Enterprise value:
-3.8B
EV / Invested capital:
-0.47x
Price / LTM sales:
2.10x
EV / EBIT:
-2.60x
EV / Revenue:
-0.68x
PEG ratio (5yr expected):
0.59x
EV / Free cash flow:
-2.84x
Price / Operating cash flow:
8.76x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.73%
Net Income Margin (TTM):
19.33%
Return On Equity:
21.68%
Return On Invested Capital:
14.48%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.2B | $5.2B | $5.5B | $1.4B | $1.5B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $8.71 | $10.08 | $11.95 | $2.88 | $3.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $21.9B | $22B | $17.3B | $18.7B | $18.1B | |
| Total Assets | $29B | $29.8B | $26B | $28.1B | $29.1B | |
| Current Liabilities | $2.5B | $2.7B | $1.4B | $1.5B | $1.7B | |
| Total Liabilities | $20.3B | $21.1B | $22B | $23.6B | $23.8B | |
| Total Equity | $8.8B | $8.6B | $3.9B | $4.5B | $5.3B | |
| Total Debt | $1.9B | $2B | $2.1B | $2.1B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $1.5B | $1.4B | $391.4M | $336.9M | |
| Cash From Investing | -$943M | -$926.1M | -$641.5M | -$98.2M | $181.4M | |
| Cash From Financing | -$492.5M | -$541.5M | -$715.8M | -$271.7M | -$501M | |
| Free Cash Flow | $1.4B | $1.4B | $1.3B | $378.3M | $321.9M | |
GL
Sector
Market Cap
$10.9B
$616.2M
Price % of 52-Week High
98.78%
85.86%
Dividend Yield
0.74%
1.99%
Shareholder Yield
9.94%
3.77%
1-Year Price Total Return
12.4%
8.45%
Beta (5-Year)
0.771
0.714
Dividend yield:
0.74%
Annualized payout:
$0.95
Payout ratio:
7.98%
Growth streak:
9 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$126.82
200-day SMA
Buy
Level
$105.06
Bollinger Bands (100)
Buy
Level
107.37 - 122.97
Chaikin Money Flow
Buy
Level
110.5M
20-day SMA
Buy
Level
$125.50
Relative Strength Index (RSI14)
Buy
Level
61.36
ADX Line
Buy
Level
23.33
Williams %R
Sell
Level
-4.1943
50-day SMA
Buy
Level
$122.15
MACD (12, 26)
Buy
Level
1.75
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
224M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.663)
Sell
CA Score
(Annual)
Level (-1.6655)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.1687)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Stock Forecast FAQ
In the current month, GL has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The GL average analyst price target in the past 3 months is $141.09.
-
Where Will Globe Life Stock Be In 1 Year?
According to analysts, the consensus estimate is that Globe Life share price will rise to $141.09 per share over the next 12 months.
-
What Do Analysts Say About Globe Life?
Analysts are divided on their view about Globe Life share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Globe Life is a Sell and believe this share price will drop from its current level to $115.00.
-
What Is Globe Life's Price Target?
The price target for Globe Life over the next 1-year time period is forecast to be $141.09 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is GL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Globe Life is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of GL?
You can purchase shares of Globe Life via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Globe Life shares.
-
What Is The Globe Life Share Price Today?
Globe Life was last trading at $129.77 per share. This represents the most recent stock quote for Globe Life. Yesterday, Globe Life closed at $129.79 per share.
-
How To Buy Globe Life Stock Online?
In order to purchase Globe Life stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is down 18.29% over the past day.
Buy
58
TNXP alert for Mar 25
Tonix Pharmaceuticals Holding [TNXP] is down 2.46% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 0.12% over the past day.
